A 60-year-old woman came into our office for her annual examination. We noted that she had lost 1.5 inches in height.
A 60-year-old woman came into our office for her annual examination. We noted that she had lost 1.5 inches in height. We secured an immediate appointment with the dual-energy x-ray absorptiometry (DXA) technician. The result was a T-score of –1.5 (low bone mass, osteopenia). The questions were: How to treat her condition? Was a prescription therapy needed? Which therapy (eg, bisphosphonate, selective estrogen-receptor modular [SERM], or parathyroid hormone [PTH]) was most appropriate? How should she be treated in light of the many complications from long-term therapy?
Eventually, our dilemma would be how to treat this woman without overtreating her. To make an appropriate decision about whether and how to treat her, associated information must be gathered, including history and laboratory results. Evaluation guidelines are followed by discussion of 3 different scenarios.
History
Laboratory workup
These tests should be ordered:
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More